ClinicalTrials.Veeva

Menu

Zenith Alpha™ Abdominal Endovascular Graft

C

Cook Group

Status

Completed

Conditions

Abdominal Aortic
Aorto-iliac Aneurysm

Treatments

Device: Zenith Alpha™ Abdominal Endovascular Graft

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to evaluate the clinical performance of the Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A patient is considered eligible for inclusion in the study if the patient has an infrarenal abdominal aortic or aorto-iliac aneurysm and is intended to be treated with the Zenith Alpha™ Abdominal Endovascular Graft

Exclusion criteria

  • Life expectancy less than (<) 2 years
  • Inability or refusal to give informed consent by the patient or legally authorized representative
  • Unwilling or unable to comply with the study follow-up

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems